Misfolded SOD1 inclusions in patients with mutations in <i>C9orf72</i> and other ALS/FTD-associated genes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30992335.
- Also identified by DOI 10.1136/jnnp-2018-319386 and PMC identifier 6691870.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A hallmark of amyotrophic lateral sclerosis (ALS) caused by mutations in <i>superoxide dismutase-1</i> (<i>SOD1</i>) are inclusions containing SOD1 in motor neurons. Here, we searched for SOD1-positive inclusions in 29 patients carrying ALS-linked mutations in six other genes. A panel of antibodies that specifically recognise misfolded SOD1 species were used for immunohistochemical investigations of autopsy tissue. The 18 patients with hexanucleotide-repeat-expansions in <i>C9orf72</i> had inclusions of misfolded wild type (WT) SOD1<sup>WT</sup> in spinal motor neurons. Similar inclusions were occasionally observed in medulla oblongata and in the motor cortex and frontal lobe. Patients with mutations in <i>FUS, KIF5A, NEK1, ALSIN</i> or <i>VAPB</i>, carried similar SOD1<sup>WT</sup> inclusions. Minute amounts of misSOD1<sup>WT</sup> inclusions were detected in 2 of 20 patients deceased from non-neurological causes and in 4 of 10 patients with other neurodegenerative diseases. Comparison was made with 17 patients with 9 different <i>SOD1</i> mutations. Morphologically, the inclusions in patients with mutations in <i>C9orf72HRE, FUS, KIF5A, NEK1, VAPB</i> and <i>ALSIN</i> resembled inclusions in patients carrying the wildtype-like <i>SOD1<sup>D90A</sup></i> mutation, whereas patients carrying unstable <i>SOD1</i> mutations (A4V, V5M, D76Y, D83G, D101G, G114A, G127X, L144F) had larger skein-like SOD1-positive inclusions. Abundant inclusions containing misfolded SOD1<sup>WT</sup> are found in spinal and cortical motor neurons in patients carrying mutations in six ALS-causing genes other than <i>SOD1</i>. This suggests that misfolding of SOD1<sup>WT</sup> can be part of a common downstream event that may be pathogenic. The new anti-SOD1 therapeutics in development may have applications for a broader range of patients.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Frontotemporal Dementia
- Mutation
- Proteostasis Deficiencies
- Superoxide Dismutase-1